CEFUROXIME FOR INJECTION USP POWDER FOR SOLUTION

Country: Kanada

Lingwa: Ingliż

Sors: Health Canada

Ingredjent attiv:

CEFUROXIME (CEFUROXIME SODIUM)

Disponibbli minn:

PHARMACEUTICAL PARTNERS OF CANADA INC

Kodiċi ATC:

J01DC02

INN (Isem Internazzjonali):

CEFUROXIME

Dożaġġ:

7.5G

Għamla farmaċewtika:

POWDER FOR SOLUTION

Kompożizzjoni:

CEFUROXIME (CEFUROXIME SODIUM) 7.5G

Rotta amministrattiva:

INTRAVENOUS

Unitajiet fil-pakkett:

77ML

Tip ta 'preskrizzjoni:

Prescription

Żona terapewtika:

SECOND GENERATION CEPHALOSPORINS

Sommarju tal-prodott:

Active ingredient group (AIG) number: 0122448003; AHFS:

L-istatus ta 'awtorizzazzjoni:

CANCELLED POST MARKET

Data ta 'l-awtorizzazzjoni:

2008-02-15

Karatteristiċi tal-prodott

PRODUCT MONOGRAPH
PR
CEFUROXIME FOR INJECTION USP
750 mg, 1.5 g, and 7.5 g cefuroxime
ANTIBIOTIC
Pharmaceutical Partners of Canada Inc.
Date of Preparation:
45 Vogell Road, Suite 200
February 6, 2008
Richmond Hill, ON L4B 3P6
Control No.: 119563
Page 2 of 46
CEFUROXIME FOR INJECTION USP
750 mg, 1.5 g, and 7.5 g cefuroxime
THERAPEUTIC CLASSIFICATION
Antibiotic
ACTION AND CLINICAL PHARMACOLOGY
_In vitro _ studies demonstrate that the bactericidal action of
cefuroxime results from
inhibition
of
bacterial
cell
wall
synthesis
by
inhibiting
the
transpeptidase
and
carboxypeptidase enzymes.
INDICATIONS AND CLINICAL USES
TREATMENT
Cefuroxime for Injection USP is indicated for the treatment of
patients with infections
caused by susceptible strains of the designated organisms in the
following diseases:
LOWER RESPIRATORY TRACT INFECTIONS
Pneumonia caused by _Streptococcus pneumoniae_, _Haemophilus
influenzae_ including
ampicillin-resistant
strains,
_Klebsiella_
species,
_Staphylococcus _
_aureus _
including
ampicillin-resistant (but not methicillin-resistant) strains,
_Streptococcus pyogenes_, and
_Escherichia coli_.
Page 3 of 46
URINARY TRACT INFECTIONS
Caused by _Escherichia coli _and _Klebsiella _species.
SOFT TISSUE INFECTIONS
Caused by _ Staphylococcus aureus _ including ampicillin-resistant
(but not methicillin-
resistant) strains, _Streptococcus pyogenes_, _Escherichia coli_,
_Klebsiella _species.
MENINGITIS
Caused by _ Staphylococcus aureus _ including ampicillin-resistant
(but not methicillin-
resistant) strains, _Streptococcus pneumoniae_, _Haemophilus
influenzae_, and _Neisseria _
_meningitidis_.
GONORRHOEA
Caused by _Neisseria gonorrhoea _including ampicillin-resistant
strains.
BONE AND JOINT INFECTIONS
Caused
by
_Staphylococcus _
_aureus _
(penicillinase
and
non-penicillinase
producing
strains).
Specimens for bacteriologic culture should be obtained prior to
therapy in order to
identify the causative organisms and to determine their susceptibility
to cefuroxime.
Therapy may be instituted before results of suscep